Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 evaluation of topical cortexolone 17α-propionate in children with acne vulgaris
2016-000616-15Phase 2Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clascoterone in acne vulgaris, sponsored by Cassiopea S.p.A. Primary endpoints: Hypothalamic-pituitary-adrenal axis response to cosyntropin and Trough plasma concentrations of cortexolone 17α-propionate. Started Apr 2016; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2016-000616-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000616-15.